Changes in D2/D3-receptor availability in detoxified patients with alcohol addiction compared to healthy subjects - a PET study with [18F]fallypride

被引:0
|
作者
Paulzen, M. [1 ]
Spreckelmeyer, K. [1 ]
Van Waesberghe, J. [1 ]
Zalewski, M. [1 ]
Baltus, T. [1 ]
Raptis, M. [1 ]
Roesch, F. [2 ]
Vernaleken, I. [1 ]
Schaefer, W. [1 ]
Gruender, G. [1 ]
机构
[1] Rhein Westfal TH Aachen, Aachen, Germany
[2] Johannes Gutenberg Univ Mainz, Mainz, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [1] Low D2/D3-receptor availability in detoxified alcoholics compared to healthy subjects - PET study with [18F]fallypride
    Paulzen, M.
    Spreckelmeyer, K. N.
    Van Waesberghe, J.
    Zalewski, M.
    Baltus, T.
    Raptis, M.
    Roesch, F.
    Vernaleken, I
    Schaefer, W. M.
    Gruender, G.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 235 - 235
  • [2] Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy:: An [18F]Fallypride PET study
    Werhahn, Konrad J.
    Landvogt, Christian
    Klimpe, Sven
    Buchholz, Hans-Georg
    Yakushev, Igor
    Siessmeier, Thomas
    Mueller-Forell, Wibke
    Piel, Markus
    Roesch, Frank
    Glaser, Martin
    Schreckenberger, Mathias
    Bartenstein, Peter
    EPILEPSIA, 2006, 47 (08) : 1392 - 1396
  • [3] [18F] FALLYPRIDE PET MEASUREMENT OF STRIATAL AND EXTRASTRIATAL DOPAMINE D2/3 RECEPTOR AVAILABILITY IN PATIENTS WITH ALCOHOL USE DISORDER
    Koller, G.
    La Fougere, C.
    Rominger, A.
    Holdtschmidt-Taeschner, B.
    Soyka, M.
    Cumming, P.
    Bartenstein, P.
    Pogarell, O.
    EUROPEAN PSYCHIATRY, 2010, 25
  • [4] Elevated D2/3-receptor availability in schizophrenia : An [18F]fallypride study
    Gruender, G.
    Veselinovic, T.
    Raptis, M.
    Janouschek, H.
    Klomp, M.
    Spreckelmeyer, K. N.
    Bartenstein, P.
    Wong, D. F.
    Roesch, F.
    Schaefer, W. M.
    Vernaleken, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 219 - 219
  • [5] Elevated D2/3-receptor availability in schizophrenia:: A [18F]fallypride study
    Vernaleken, Ingo
    Eickhoff, S. B.
    Veselinovic, T.
    Klomp, M.
    Spreckelmeyer, K.
    Schaefer, W.
    Gruender, G.
    NEUROIMAGE, 2008, 41 : T145 - T145
  • [6] Striatal and extrastriatal dopamine D2 receptor availability as assessed by [18F]fallypride and PET in patients with alcohol use disorder
    Koller, G.
    Rominger, A.
    La Fougere, C.
    Cumming, P.
    Bartenstein, P.
    Soyka, M.
    Pogarell, O.
    PHARMACOPSYCHIATRY, 2011, 44 (06)
  • [7] Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability:: A combined [18F]DOPA and [18F]DMFP PET Study in detoxified alcoholic patients
    Heinz, A
    Siessmeier, T
    Wrase, J
    Buchholz, HG
    Gründer, G
    Kumakura, Y
    Cumming, P
    Schreckenberger, M
    Smolka, MN
    Rösch, F
    Mann, K
    Bartenstein, P
    AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (08): : 1515 - 1520
  • [8] Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
    Grachev, Igor D.
    Meyer, Philipp M.
    Becker, Georg A.
    Bronzel, Marcus
    Marsteller, Doug
    Pastino, Gina
    Voges, Ole
    Rabinovich, Laura
    Knebel, Helena
    Zientek, Franziska
    Rullmann, Michael
    Sattler, Bernhard
    Patt, Marianne
    Gerhards, Thilo
    Strauss, Maria
    Kluge, Andreas
    Brust, Peter
    Savola, Juha-Matti
    Gordon, Mark F.
    Geva, Michal
    Hesse, Swen
    Barthel, Henryk
    Hayden, Michael R.
    Sabri, Osama
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (04) : 1103 - 1115
  • [9] [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in acutely abstinent alcoholics
    Rominger, Axel
    Xiong, Guoming
    Koller, Gabriele
    Waengler, Bjoern
    Bartenstein, Peter
    Cumming, Paul
    Pogarell, Oliver
    la Fougere, Christian
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [10] Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
    Igor D. Grachev
    Philipp M. Meyer
    Georg A. Becker
    Marcus Bronzel
    Doug Marsteller
    Gina Pastino
    Ole Voges
    Laura Rabinovich
    Helena Knebel
    Franziska Zientek
    Michael Rullmann
    Bernhard Sattler
    Marianne Patt
    Thilo Gerhards
    Maria Strauss
    Andreas Kluge
    Peter Brust
    Juha-Matti Savola
    Mark F. Gordon
    Michal Geva
    Swen Hesse
    Henryk Barthel
    Michael R. Hayden
    Osama Sabri
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1103 - 1115